CastleVax
Biotechnology Research
7 employees
- Employees
- 7
- Contacts
- 3
- Emails
- 3
- Phones
- 3
CastleVax Overview
- Website
- www.castlevax.com
- Industry
- Biotechnology Research
- Employees
- 7
- Funding
- 34.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About CastleVax
CastleVax is the proven technology that will bring safe vaccines for all humans, everywhere. Our state-of-the-art platform for producing first-in-class vaccines uses Newcastle Disease Virus (NDV) to enable rapid development of safe and highly immunogenic viral vectors that are easy to deliver and store, and can be administered via injection or intranasally.
CastleVax Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 3
- 75.0% coverage
CastleVax Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Erik Lium | Chief Commercial Innovation Officer | New York, United States |
Email
Phone
|
| Matthew Stober | CEO - Pharma & Biotech Board Member |
View
|
|
| Michael Egan | Ceo/cso at Castlevax | Tucson, Arizona, United States |
Email
Phone
|
| Danny Wood | Director of Clinical Operations | San Antonio, Texas, United States |
Email
Phone
|
Employees by Management Level
Executive
3 profiles
Director
1 profile
Compare Similar Companies to CastleVax
CEPI (Coalition for Epidemic Preparedness Innovations)
Research Services
Abzena
Pharmaceutical Manufacturing
Leiters Health
Pharmaceutical Manufacturing
Oula
Hospitals And Health Care
GeoVax Labs, Inc.
Biotechnology Research
Micron Biomedical
Biotechnology Research
Decoy Therapeutics Inc.
Biotechnology Research
CyanVac LLC
Biotechnology Research
Immunyx Pharma
Biotechnology Research
Ceramedix, Inc. (EFL ‘25)
Biotechnology Research